HPV Vaccine Communication: Special considerations for a unique vaccine
This report presents communication guidance and specific considerations for countries that plan to introduce human papillomavirus (HPV) vaccine into their national immunization programme. New vaccine introduction is a hallmark of the Decade of Vaccines, but HPV vaccine is unique for many reasons. This report aims to offer guidance in two main areas: The first is to offer advice on basic communication planning and implementation for immunization; the second is to discuss specific considerations for HPV vaccine.
What is new in the 2016 update:
- WHO’s October 2014 changes to the recommended HPV vaccine schedule.
- Updated facts, evidence and experience from low, middle and high-income countries that have introduced HPV vaccine.
- An enhanced section on crisis communication.
- Additional information about the opportunities for integration with comprehensive cervical cancer programs and adolescent health interventions and on the consent process.